Galectin Therapeutics Insider Trades

GALT

Track insider trading activity from Galectin Therapeutics executives and directors. See which insiders are buying and selling GALT stock.

Trades Last 12 Months

GALT Price

All Insider Trades for Galectin Therapeutics

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Holding Value $154k 28,768 shares
Last Trade
Jun 29, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$111k 22,268 shares
$4.97
$5.34
Jamil Khurram Chief Medical Officer
Holding Value $253k 47,467 shares
Last Trade
Jun 29, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$236k 47,467 shares
$4.97
$5.34
Brem Henry Director
Holding Value $320k 60,000 shares
Last Trade
Mar 12, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$190k 60,000 shares
$3.16
$5.34
Eldred Kary Director
Holding Value $351k 65,682 shares
Last Trade
Feb 06, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$810 300 shares
$2.70
$5.34
Holding Value $320k 60,000 shares
Last Trade
Jan 16, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$182k 60,000 shares
$3.04
$5.34
Omenn Gilbert S Director
Holding Value $320k 60,000 shares
Last Trade
Jan 16, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$182k 60,000 shares
$3.04
$5.34
Amelio Gilbert F Director
Holding Value $320k 60,000 shares
Last Trade
Jan 16, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$182k 60,000 shares
$3.04
$5.34
Callicutt Jack W Chief Financial Officer
Holding Value $534k 100,000 shares
Last Trade
Jan 16, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$304k 100,000 shares
$3.04
$5.34
Holding Value $320k 60,000 shares
Last Trade
Jan 16, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$182k 60,000 shares
$3.04
$5.34
Uihlein Richard E 10% owner
Holding Value $55.2M 10,332,676 shares
Last Trade
Jan 16, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$222k 73,158 shares
$3.04
$5.34
Freeman Kevin D Director
Holding Value $320k 60,000 shares
Last Trade
Jan 16, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$182k 60,000 shares
$3.04
$5.34
Lewis Joel President And CEO
Holding Value $486k 91,000 shares
Last Trade
Jan 16, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$277k 91,000 shares
$3.04
$5.34
Holding Value $320k 60,000 shares
Last Trade
Jan 16, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$182k 60,000 shares
$3.04
$5.34
10 X Fund, L.P. 10% owner
Holding Value $30M 5,614,457 shares
Last Trade
Dec 16, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$204k 30,681 shares
$6.66
$5.34
Czirr James C 10% owner
Holding Value $5.58M 1,045,541 shares
Last Trade
Jun 06, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$52.8k 40,000 shares
$1.32
$5.34
Rubin Marc Director
Holding Value $320k 60,000 shares
Last Trade
Jan 23, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$73.8k 60,000 shares
$1.23
$5.34
Boudes Pol F Chief Medical Officer
Holding Value $347k 65,000 shares
Last Trade
Jan 24, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$112k 65,000 shares
$1.72
$5.34
Shulman Stephen Director
Holding Value $134k 25,000 shares
Last Trade
Jan 16, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$118k 25,000 shares
$4.72
$5.34
Traber Peter G President & CEO
Holding Value $1.11M 207,333 shares
Last Trade
Jun 13, 2018 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$782k 100,000 shares
$7.82
$5.34
Holding Value $5.78k 1,083 shares
Last Trade
Apr 16, 2018 Sale (Open Market)Shares sold on the open market or in a private sale.
$14.3k 4,000 shares
$3.58
$5.34

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up